Yargesa

Medicinal product

(Invented) name

Yargesa

Active substance (s)

Migliustatas

Strength

100 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A16AX06, Miglustat

Marketing authorisation holder

Piramal Critical Care B.V., Nyderlandai

Date of authorisation

2017-03-22

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Capsule, hard	1 vnt.
Migliustatas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68055	82617	1082617	lizdinė plokštelė	N84x1		Receptinis	EU/1/17/1176/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-03-22	Registruotas